APA (7th ed.) Citation

H, K., M, T., S, K., K, K., E, A., & Y, T. (2018). Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia. Dove Medical Press.

Chicago Style (17th ed.) Citation

H, Katagiri, Taketsuna M, Kondo S, Kajimoto K, Aoi E, and Tanji Y. Effectiveness and Safety of Oral Olanzapine Treatment Transitioned from Rapid-acting Intramuscular Olanzapine for Agitation Associated with Schizophrenia. Dove Medical Press, 2018.

MLA (8th ed.) Citation

H, Katagiri, et al. Effectiveness and Safety of Oral Olanzapine Treatment Transitioned from Rapid-acting Intramuscular Olanzapine for Agitation Associated with Schizophrenia. Dove Medical Press, 2018.